• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. ¿ US ACUVUE VITA; SOFT CONTACT LENS, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. ¿ US ACUVUE VITA; SOFT CONTACT LENS, DAILY WEAR Back to Search Results
Catalog Number ATL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Perforation (1792); Foreign Body Sensation in Eye (1869); Blurred Vision (2137)
Event Date 07/27/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter¿s phone number: (b)(6).
 
Event Description
On (b)(6) 2020, an eye care provider (ecp) in (b)(6) reported a patient (pt) experienced ¿corneal damaged¿ after wearing an acuvue® vita¿ brand contact lens.No further information was provided.On 31jul2020, additional information was received from the pt: the pt reported experiencing blurry vision in the right eye (od) on the third day of wearing the cl ((b)(6) 2020).The pt experienced foreign body sensation upon removal of the contact lens.The pt visited the doctor and was diagnosed with ¿corneal rupture.¿ the pt was prescribed: recombinant human epidermal growth factor eye drops to use 1-2 drops, 6-8 times a day; compound tropicamide eye drops to use 1 drop every 5 minutes, 4 times and then discontinue; tobramycin eye drop to use 1-2 drops, 2-3 times a day; ofloxacin eye ointment to use 2-3 times a day.The pt returned to the doctor for a follow-up on (b)(6) 2020 and was advised to continue using recombinant human epidermal growth factor eye drops 6-8 times a day but can reduce the amount of other eye drops (unspecified).No further information was provided.Multiple attempts have been made to contact the pt to obtain additional information.No further information has been received.The suspect od contact lens was discarded.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00v442 was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE VITA
Type of Device
SOFT CONTACT LENS, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. ¿ US
7500 centurion parkway
jacksonville FL
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433364
MDR Report Key10431573
MDR Text Key210230079
Report Number1057985-2020-00041
Device Sequence Number1
Product Code LPL
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K160212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Reporter Occupation Physician
Type of Report Initial
Report Date 08/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberATL
Device Lot NumberB00V442
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/31/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/28/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-